During the past decade, Norton Healthcare conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 34 clinical trials were completed, i.e. on average, 45.3% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 26 clinical trials were completed. i.e. 70.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norton Healthcare" #1 sponsor was "NSABP Foundation Inc" with 8 trials, followed by "National Cancer Institute (NCI)" with 7 trials sponsored, "Pfizer" with 7 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored and "University of Louisville" with 7 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norton Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Norton Healthcare" with 3 trials as a collaborator and "Radiation Therapy Oncology Group" with 3 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Norton Healthcare" are "Breast Cancer" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "COVID-19" (4 trials) and "Non-Small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Norton Healthcare" in a lesser frequency.

Most popular intervention types in "Norton Healthcare" are "Drug" (74 trials), "Other" (30 trials), "Device" (20 trials), "Biological" (18 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (6 trials), "Quality-of-Life Assessment" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Norton Healthcare" are 96 trials for "All" genders, 26 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 46 active trials in "Norton Healthcare". 1 are not yet recruiting, 23 are recruiting, 19 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 52 completed trials in Norton Healthcare, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Norton Healthcare, 12 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 16 trials that are defined as “Not Applicable".